SN

Sumit Nanuram Jakhad

Active Director Designated Partner DIN 11156811
DIN 11156811 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sumit Nanuram Jakhad

Data last updated:

Sumit Nanuram Jakhad is a Designated Partner at Cure Path Pharma Llp (since 2025).

DIN 11156811
Primary Designation Designated Partner
First Appointment 16 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Jun 20252025Active

Board colleagues of Sumit Nanuram Jakhad

NameDINCompanyDesignation
Bhagirath Jagdish Jakhad08304964Cure Path Pharma LlpDesignated Partner
Rampal Dhannaram Jakhad08304984Cure Path Pharma LlpDesignated Partner
Rishab Atul Trivedi11156810Cure Path Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cure Path Pharma Llp
Premium access

Shareholding and investment profile for Sumit Nanuram Jakhad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Nanuram Jakhad

Sumit Nanuram Jakhad currently holds 1 directorship: Cure Path Pharma Llp (Designated Partner, since 16 Jun 2025).

Sumit Nanuram Jakhad was first appointed on 16 Jun 2025 as Designated Partner at Cure Path Pharma Llp.

The current boards of Sumit Nanuram Jakhad's companies include Bhagirath Jagdish Jakhad (Cure Path Pharma Llp), Rampal Dhannaram Jakhad (Cure Path Pharma Llp), Rishab Atul Trivedi (Cure Path Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available